Working… Menu
Trial record 1 of 1 for:    Soricimed
Previous Study | Return to List | Next Study

Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01578564
Recruitment Status : Completed
First Posted : April 17, 2012
Last Update Posted : June 23, 2016
Information provided by (Responsible Party):
Soricimed Biopharma Inc

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2015
Actual Study Completion Date : March 2016